FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

410576006: Cycloplegic agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2466028016 Cycloplegic agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2472232016 Cycloplegic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2466028016 Cycloplegic agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2466028016 Cycloplegic agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2472232016 Cycloplegic agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2472232016 Cycloplegic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    192001000077114 agent cycloplégique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
    192001000077114 agent cycloplégique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    agent cycloplégique Is a agent ophtalmique false Inferred relationship Existential restriction modifier (core metadata concept)
    agent cycloplégique Is a Muscarinic receptor antagonist false Inferred relationship Existential restriction modifier (core metadata concept)
    agent cycloplégique Has disposition Muscarinic receptor antagonist false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Atropine sulfate 10 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 10 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cyclopentolate hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate hydrochloride 1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate hydrochloride 0.5% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely homatropine hydrobromide 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 20 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 2% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide 0.25% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 0.5% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydroxyamphetamine hydrobromide and tropicamide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.031% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.062% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.1% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 0.25% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 5 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 1% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 20 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate hydrochloride 1% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 0.125% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 0.25% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 0.5% eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 1% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 2% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide 0.125% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide 0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine eye preparations (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine sulfate 5 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing cyclopentolate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing tropicamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cycloplegic preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Hyoscine hydrobromide [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine hydrobromide 5% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate hydrochloride 2% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide 5mg solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Antispasmodic homatropine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Ophthalmic hyoscine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine methylbromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate hydrochloride + phenylephrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing homatropine methylbromide and hydrocodone bitartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Atropine (substance) Is a False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Homatropine Is a False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Cyclopentolate (substance) Is a False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Scopolamine (substance) Is a False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)
    Tropicamide (substance) Is a False agent cycloplégique Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start